Radioligand
Therapy
Academy
The RLT Academy project aims to promote education of radioligand therapies in Europe and bridge the educational gap among healthcare professionals.
In collaboration wih 14 organisations
What is Radioligand Therapy
Radioligand therapy (RLT) is an innovative approach to cancer treatment that delivers radiation directly to tumour cells (with the help of radioisotopes), regardless of where they are inside the body, while minimising the damage to all the healthy tissue that surrounds the tumour cells.
It is a major milestone in cancer therapy.
Our Objectives
MAP
the knowledge gap in RLTs
BRIDGE
the knowledge gap that currently exists among healthcare professionals
PROMOTE
the integration of RLTs into mainstream cancer care
Current Landscape of RLT in Europe
We performed a systematic survey to assess the existing gaps in Europe in multidisciplinary education for integration of radioligand therapy (RLT) into cancer care and to obtain detailed information on the current limitations and key contents relevant.
A high-quality questionnaire, with emphasis on survey scales, formulation, and validity of the different items, was designed. An expert validation process was undertaken. The survey was circulated among medical specialties involved in cancer treatment, universities, and nursing organizations.
